Related scientific articles (all)

Quality assurance (QA) in radiotherapy : how important is it ? (ICACT)

Authors : Van Gestel D, Dragan T, Beauvois S
Year : 2016
Journal : Book
Volume : -
Pages : 44-48

Emerging Drugs Targeting Human Epidermal Growth Factor Receptor 2 (Her2) In The Treatment Of Breast Cancer.

Authors : Awada G, Gombos A, Aftimos P, Awada A
Year : 2016
Journal : Expert Opin Emerg Drugs
Volume : 21(1)
Pages : 91-101

Classical risk factors, but not HPV status, predict survival after chemoradiotherapy in advanced head and neck cancer patients.

Authors : Descamps G, Karaca Y, R Lechien J, Kindt N, Decaestecker C, Remmelink M, Larsimont D, Andry G, Hassid S, Rodriguez A, Khalife M, Journe F, Saussez S
Year : 2016
Journal : J Cancer Res Clin Oncol
Volume : 142(10)
Pages : 2185-96

A little help from steroids in oncology.

Authors : Lossignol D
Year : 2016
Journal : J Transl Int Med
Volume : 4(1)
Pages : 52-54

MULTIFOCALITY IN SPORADIC MEDULLARY THYROID CARCINOMA: AN INTERNATIONAL MULTICENTER STUDY.

Authors : Essig G Jr, Porter K, Schneider DF, Arpaia D, Lindsey SC, Busonero G, Fineberg D, Fruci B, Boelaert K, Smit J, Meijer J, Duntas LH, Sharma N, Costante G, Filetti S, Sippel RS, Biondi B Md, Topliss DJ, Pacini F, Maciel RM, Walz P, Kloos RT
Year : 2016
Journal : Thyroid
Volume : 26
Pages : 1563-72

The topography of mutational processes in breast cancer genomes.

Authors : Morganella S, Alexandrov LB, Glodzik D, Zou X, Davies H, Staaf J, Sieuwerts AM, Brinkman AB, Martin S, Ramakrishna M, Butler A, Kim HY, Borg Å, Sotiriou C, Futreal PA, Campbell PJ, Span PN, Van Laere S, Lakhani SR, Eyfjord JE, Thompson AM, Stunnenberg HG, Van de Vijver MJ, Martens JW, Børresen-Dale AL, Richardson AL, Kong G, Thomas G, Sale J, Rada C, Stratton MR, Birney E, Nik-Zainal S
Year : 2016
Journal : Nat Commun
Volume : 7
Pages : 11383

Immune checkpoint inhibitors renal side effects and management.

Authors : Rassy EE, Kourie HR, Rizkallah J, Karak FE, Hanna C, Chelala DN, Ghosn M
Year : 2016
Journal : Immunotherapy
Volume : 8
Pages : 1417-1425

Preoperative Assessment and Intervention: Optimizing Outcomes for Early Return of Urinary Continence (in Urinary Continence and Sexual Function After Robotic Radical Prostatectomy pp 35-42

Authors : Aoun F, Albisinni S, Limani K, Van Velthoven R
Year : 2016
Journal : Book
Volume : --
Pages : 35-42

Long term follow up of the EORTC 18952 trial of adjuvant therapy in resected stage IIB-III cutaneous melanoma patients comparing intermediate doses of interferon-alpha-2b (IFN) with observation: Ulceration of primary is key determinant for IFN-sensit

Authors : Eggermont AM, Suciu S, Rutkowski P, Kruit WH, Punt CJ, Dummer R, Sales F, Keilholz U, de Schaetzen G, Testori A
Year : 2016
Journal : Eur J Cancer
Volume : 55
Pages : 111-121

A 38 years old female with inflammatory myofibroblastic tumor and lactic acidosis.

Authors : Gorham J, Liberale G, Haydar HN, de Saint-Aubain de Somerhausen N, Meert AP
Year : 2016
Journal : Rev Med Brux
Volume : 37
Pages : 104-7

Phase I Study of the Prolactin Receptor Antagonist LFA102 in Metastatic Breast and Castration-Resistant Prostate Cancer.

Authors : Agarwal N, Machiels JP, Suárez C, Lewis N, Higgins M, Wisinski K, Awada A, Maur M, Stein M, Hwang A, Mosher R, Wasserman E, Wu G, Zhang H, Zieba R, Elmeliegy M
Year : 2016
Journal : Oncologist
Volume : 21(5)
Pages : 535-6

Dermatologic adverse events of checkpoint inhibitors: what an oncologist should know.

Authors : Habre M, Habre SB, Kourie HR
Year : 2016
Journal : Immunotherapy
Volume : 8
Pages : 1437-1446

Nutrition et prévention du cancer : changer les mentalités

Authors : Awada A
Year : 2016
Journal : Onco-Hémato
Volume : -
Pages : -

The Genomic Grade Assay Compared With Ki67 to Determine Risk of Distant Breast Cancer Recurrence.

Authors : Ignatiadis M, Azim HA Jr, Desmedt C, Veys I, Larsimont D, Salgado R, Lyng MB, Viale G, Leyland-Jones B, Giobbie-Hurder A, Kammler R, Dell orto P, Rothé F, Laïos I, Ditzel HJ, Regan MM, Piccart-Gebhart M, Michiels S, Sotiriou C
Year : 2016
Journal : JAMA Oncol
Volume : 2(2)
Pages : 217-24

Adjuvant chemotherapy in elderly patients with breast cancer: key challenges.

Authors : Pondé N, Dal Lago L, Azim HA Jr
Year : 2016
Journal : Expert Rev Anticancer Ther
Volume : 16(6)
Pages : 661-71

Improved Treatment of Breast Cancer with Anti-HER2 Therapy Requires Interleukin-21 Signaling in CD8+ T Cells.

Authors : Mittal D, Caramia F, Michiels S, Joensuu H, Kellokumpu-Lehtinen PL, Sotiriou C, Loi S, Smyth MJ
Year : 2016
Journal : Cancer Res
Volume : 76
Pages : 264-74

Comparing conventional laparoscopic to robotic-assisted extended pelvic lymph node dissection in men with intermediate and high-risk prostate cancer: a matched-pair analysis.

Authors : Albisinni S, Aoun F, Le Dinh D, Zanaty M, Hawaux E, Peltier A, Van Velthoven R
Year : 2016
Journal : Minerva Urol Nefrol
Volume : 28(25)
Pages : 2941-48

News on the medical treatment of young women with early-stage HER2-negative breast cancer.

Authors : Lambertini M, Poggio F, Vaglica M, Blondeaux E, Del Mastro L
Year : 2016
Journal : Expert Opin Pharmacother
Volume : 17
Pages : 1643-1655

Feasibility Study of EndoTAG-1, a Tumor Endothelial Targeting Agent, in Combination with Paclitaxel followed by FEC as Induction Therapy in HER2-Negative Breast Cancer.

Authors : Ignatiadis M, Zardavas D, Lemort M, Wilke C, Vanderbeeken MC, Dhondt V, de Azambuja E, Gombos A, Lebrun F, Dal Lago L, Bustin F, Maetens M, Ameye L, Veys I, Michiels S, Paesmans M, Larsimont D, Sotiriou C, Nogaret JM, Piccart-Gebhart M, Awada A
Year : 2016
Journal : PLoS One
Volume : 11(7)
Pages : e0154009

Missing metastases as a model to challenge current therapeutic algorithms in colorectal liver metastases.

Authors : Lucidi V, Hendlisz A, Van Laethem JL, Donckier V
Year : 2016
Journal : World J Gastroenterol
Volume : 22
Pages : 3937-44